Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Pharmacielo Ltd V.PCLO

Alternate Symbol(s):  PCLOF

PharmaCielo Ltd. is a Canada-based company with a focus on ethical and sustainable processing and supplying of all natural, pharmaceutical-grade medical cannabis products to channel distributors. The Company has two subsidiaries, PharmaCielo Colombia Holdings S.A.S. (PharmaCielo Colombia) and Ubiquo Telemedicina S.A.S. (Ubiquo). PharmaCielo Colombia cultivates and processes the Company’s all-natural cannabis into standardized, medicinal-grade oil extracts and related products. In Colombia, PharmaCielo Colombia is a licensed cultivator, producer, and distributor of both TetraHydroCannabinol (THC) and Cannabidiol (CBD) medical cannabis for use in Colombia, international export, and research purposes. Ubiquo is a knowledge management and medical consultation system that focuses on creating access to healthcare for Colombians. Ubiquo is a technology platform and a user interface that allows doctors and patients to communicate. Ubiquo is used as a communication tool.


TSXV:PCLO - Post by User

Post by mmaltaison Dec 07, 2022 4:31pm
262 Views
Post# 35157431

insiders Marc Lustig bought a lot of shares on nov 25th

insiders Marc Lustig bought a lot of shares on nov 25thFiling
DateTransaction
DateInsider NameOwnership
TypeSecuritiesNature of transactionVolume or ValuePriceNov 30/22Nov 25/22Lustig, MarcDirect OwnershipCommon Shares10 - Acquisition in the public market45,000$0.440
Nov 30/22Nov 25/22Lustig, MarcDirect OwnershipCommon Shares10 - Acquisition in the public market4,000$0.435
Nov 30/22Nov 25/22Lustig, MarcDirect OwnershipCommon Shares10 - Acquisition in the public market85,500$0.420
Nov 30/22Nov 25/22Lustig, MarcDirect OwnershipCommon Shares10 - Acquisition in the public market4,500$0.415
Nov 30/22Nov 25/22Lustig, MarcDirect OwnershipCommon Shares10 - Acquisition in the public market1,000$0.410
Nov 30/22Nov 25/22Lustig, MarcDirect OwnershipCommon Shares10 - Acquisition in the public market10,000$0.400
Nov 30/22Nov 25/22Lustig, MarcIndirect OwnershipCommon Shares10 - Acquisition in the public market20,000$0.400
Nov 30/22Nov 25/22Lustig, MarcIndirect OwnershipCommon Shares10 - Acquisition in the public market15,000$0.380
Nov 30/22Nov 25/22Lustig, MarcIndirect OwnershipCommon Shares10 - Acquisition in the public market11,000$0.390
Nov 30/22Nov 25/22Lustig, MarcIndirect OwnershipCommon Shares10 - Acquisition in the public market4,000$0.385
<< Previous
Bullboard Posts
Next >>